2 studies found for:    10379968 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
Conditions: Sarcoma;   Wilm's Tumor;   Lymphoma;   Neuroblastoma
Intervention: Drug: Ipilimumab(anti-CTLA-4 antibody)
2 Recruiting Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Conditions: Sarcoma;   Endocrine Tumors;   Neuroblastoma;   Retinoblastoma;   Renal Cancer
Intervention:

Indicates status has not been verified in more than two years